Identifies essential fatty acids and their metabolites, including eicosanoids, and the beneficial role fatty acids play in maintaining health. Describes clinical implications of omega-3 fatty acid deficiency and issues surrounding supplementation with these compounds. Discusses possible clinical benefits of supplementation with omega-3 fatty acids for various conditions, including neurologic, cardiovascular and immunologic pathology. Identifies issues related to mercury contamination of food sources, including fish and other seafood, and proper dietary recommendations for various categories of patients, including pregnant women, patients with essential fatty acid deficiencies, and patients with neurologic concerns.
Identifies pharmacological, herbal, and integrative approaches useful in remission-oriented management of unipolar depression/major depressive disorder and bipolar disorder. Outlines the issues of neurotransmitter-affecting medications, associated side effects, and interactions with other medications, including drugs used in dental practice. Discusses the optimal strategies for treatment augmentation in cases of treatment-resistant depression. Discusses experimental treatments for depression (e.g., transcranial magnetic therapy and vagus nerve stimulation) with patients.
Identifies typical symptoms of Parkinson’s disease and ALS. Describes approaches to diagnosing Parkinson’s disease and ALS. Identifies available options for aiding patients with Parkinson’s disease or ALS, including medications, occupational and physical therapy, and assistive devices that may benefit a patient. Describes possible future therapeutic approaches for treating Parkinson’s disease and ALS.
Identifies the basic neurophysiology, pathogenesis, etiology, and diagnosis of affective unipolar disorder/major depressive disorder (UD/MDD) and bipolar disorder (BD). Discusses the involvement of various chemical imbalances in these affective disorders, including neurotransmitters and neurohormones such as serotonin, norepinephrine, dopamine and cortisol. Lists the differential diagnosis of these conditions and the management of both disorders. Describe the spectrum of available pharmacological, psychotherapeutic, and experimental therapies for both conditions.
Describes the origin and goals of the new “positive psychology.” Lists the factors that contribute to happiness and life satisfaction. Discusses the research findings related to happiness and life satisfaction. Lists several activities and exercises that can enhance happiness and life satisfaction.
Defines various forms of bullying, associated behavioral traits, and prevalence. Describes individual, family, and social factors related to child and youth bullying. Explains bias-based bullying including race, ethnicity, gender, sexual orientation, disabilities. Discusses cyber bullying and associated problems. Describes bullying within friendships. Discusses intervention and treatment strategies for child and youth bullying. Outlines the problem of office and workplace bullying and how to respond to it.
Defines social anxiety. Describes the symptoms of social anxiety. Identifies the causes of social anxiety. Describes the similarities and differences between shyness and social anxiety. Outlines the role of thinking in social anxiety. Describes strategies for coping with and reducing social anxiety.
Identifies the physiologic, pharmacologic, and psychoneurologic properties of stimulants. Outlines the issues of caffeine toxicity, caffeine withdrawal, and management of caffeine-related disorders. Describes the mechanisms involved in amphetamine addiction and approaches to management of this condition. Identifies stimulants and stimulant-like medications used in weight reduction and appetite suppression.